In patients with AD and some AD mouse models, CRMP2 phosphorylation levels are abnormally high in cerebral cortex and hippocampus and can be detected before the formation of amyloid plaques and neurofibrillary tangles, suggesting that it is an early event in AD pathogenesis (Cole et al., 2007). The gene discussed is DPYSL2; the disease is Alzheimer disease.